New medication offers less frequent doses to reduce bleeding episodes in patients with Hemophilia A and B. The U.S. Food and Drug Administration has recently approved Qfitlia (fitusiran)…
Read MoreHemophilia
FDA Approves Gene Therapy for Hemophilia A
Severe cases of the bleeding disorder can be life-threatening. The U.S. Food and Drug Administration (FDA) has granted approval for Roctavian, gene therapy for adults with severe hemophilia…
Read More